BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28356002)

  • 1. Prognostic Parameters for Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in an Asian Population.
    Lokeskrawee T; Muengtaweepongsa S; Patumanond J; Tiamkao S; Thamangraksat T; Phankhian P; Pleumpanupatand P; Sribussara P; Kitjavijit T; Supap A; Rattanaphibool W; Prisiri J
    Curr Neurovasc Res; 2017; 14(2):169-176. PubMed ID: 28356002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score.
    Lokeskrawee T; Muengtaweepongsa S; Patumanond J; Tiamkao S; Thamangraksat T; Phankhian P; Pleumpanupat P; Sribussara P; Kitjavijit T; Supap A; Rattanaphibool W; Prisiri J
    J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2622-2629. PubMed ID: 28826584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram to Predict Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in Asian Population.
    Xie X; Yang J; Ren L; Hu S; Lian W; Xiao J; Pan L; Deng L; Ma J
    Curr Neurovasc Res; 2021; 18(5):543-551. PubMed ID: 34951382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose rt-PA may not decrease the incidence of symptomatic intracranial haemorrhage in patients with high risk of symptomatic intracranial haemorrhage.
    Liu M; Pan Y; Zhou L; Wang Y
    Neurol Res; 2019 May; 41(5):473-479. PubMed ID: 30822264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
    Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
    Stroke; 2014 Apr; 45(4):1000-6. PubMed ID: 24603072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
    Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
    Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA).
    Marsh EB; Gottesman RF; Hillis AE; Urrutia VC; Llinas RH
    Medicine (Baltimore); 2013 Nov; 92(6):317-323. PubMed ID: 24145699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for symptomatic intracranial hemorrhage after intravenous thrombolysis with acute ischemic stroke within 6 h in northern China: a multicenter, retrospective study.
    Xue Y; Li S; Xiang Y; Wang Z; Wang F; Yu Y; Yan P; Liu X; Sun Q; Du Y; Li J
    BMC Neurol; 2022 Jan; 22(1):6. PubMed ID: 34980004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic intracranial haemorrhage after thrombolysis with adjuvant anticoagulation in basilar artery occlusion.
    Sairanen T; Strbian D; Ruuskanen R; Silvennoinen H; Salonen O; Lindsberg PJ
    Eur J Neurol; 2015 Mar; 22(3):493-9. PubMed ID: 25482105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center.
    Orlando A; Wagner JC; Fanale CV; Whaley M; McCarthy KL; Bar-Or D
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):969-76. PubMed ID: 26856464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
    Menon BK; Saver JL; Prabhakaran S; Reeves M; Liang L; Olson DM; Peterson ED; Hernandez AF; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2012 Sep; 43(9):2293-9. PubMed ID: 22811458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
    Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
    Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.